>Gradually recovering from Argentina’s devaluation - Revenues increased 1% y-o-y in Q3 (vs +5% in Q2, -1% in Q1 and -20% in Q4) to € 525m, broadly aligned with our estimates and the consensus, with a still very negative forex impact (-21pp this quarter vs -41pp in Q2, -49pp in Q1 and -60pp in Q4). This headline sales soft evolution is mainly due to the impact derived from the Argentine peso devaluation in late December 2023 and its translation to the accounts with IA...
>Gradually recovering from Argentina’s devaluation - Revenues increased 5% y-o-y in Q2 (vs -1% in Q1, -20% in Q4 and -3% in Q3) to € 528m, broadly aligned with our estimates and the consensus, with a very negative forex impact (-41pp this quarter vs -49pp in Q1 and -60pp in Q4). This headline sales soft evolution is mainly due to the impact derived from the Argentine peso devaluation in late December 2023 and its translation to the accounts with IAS 29 hyperinflation...
>Gradually recovering from Argentina’s devaluation - Revenues decreased 1% y-o-y in Q1 (vs -20% in Q4 and -3% in Q3) to € 470m, broadly aligned with our estimates yet a touch below the consensus, with a very negative forex impact (-49pp this quarter vs - 60pp in Q4). This headline sales decline is mainly due to the impact derived from the Argentine peso devaluation in late December 2023 and its translation to the accounts with IAS 29 hyperinflation rules, which noneth...
>Sales and EBITDA hit by Argentina’s devaluation - Revenues decreased 20% y-o-y in Q4 (vs -3% in Q3 and +6% in Q2) to € 364m, 11% above our estimates yet 7% below the consensus, with a very negative forex impact (-60pp this quarter vs - 54pp in Q3). This headline sales decline is mainly due to the impact derived from the Argentine peso devaluation in late December 2023 and its translation to the accounts with IAS 29 hyperinflation rules (€/ARS at 911 vs 370 in Q3 2023...
>Q4 preview: FX revaluation - The company is due to publish its Q4 2023 results on 28 February before the market opens. We expect total sales to decline -28% y-o-y to € 517m (vs -39% in Q3 and -1% in Q2). This headline sales decline is mainly due to the FX impact from the Argentine peso devaluation in late December 2023 and its translation to the accounts with IAS 29 hyperinflation rules (EUR/ARS at 906 vs 370 in Q3 2023 vs 144 in Q3 2022). This sudden drop comes fr...
Since begin July 2023 Triodos Bank (TB) has been quoted at the multilateral trading facility (MTF) Captin, where each week on a Wednesday a price is being determined. For the next few years, we estimate an EPS of about € 5.5, a circa 6.0% ROE and an IFRS book value per share of about € 91 end 2023. TB is quoting at a PE of about 4.5x and a P/B of about 0.25x. For the fair value PE of TB, we take a material discount on the bank peer group PE which is now at 5-8x. We identified five dis...
Since begin July 2023 Triodos Bank (TB) has been quoted at the multilateral trading facility (MTF) Captin, where each week on a Wednesday a price is being determined. For the next few years, we estimate an EPS of about € 5.5, a circa 6.0% ROE and an IFRS book value per share of about € 91 end 2023. TB is quoting at a PE of about 4.5x and a P/B of about 0.25x. For the fair value PE of TB, we take a material discount on the bank peer group PE which is now at 5-8x. We identified five dis...
>Organic pace accelerates but so does the FX deterioration - Revenues decreased by 3% y-o-y in Q3 (vs +6% in Q2 2023 and +16% in Q1 2023) to € 518m, in line with our estimate and the consensus, with very negative FX (-54pp this quarter vs -35pp in Q2 2023 and -19pp in Q1 2023). The comp was harder than in the previous quarters as Q2-Q3 2022 saw a return to normality after the Omicron outbreak. Organic growth accelerated the solid pace seen in previous quarters, reachi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.